Prudential Investment & Securities Co. launches a new product “Pru Global Healthcare Equity Fund”
Prudential Asset Management Co. (PAMC) will sub-advise the management of “Pru Global Healthcare Equity Fund,” distributed by PISC, to Sectoral Asset Management (S.A.M.) and the following are the characteristics of the product.
First, the product invests 60 percent or more of the assets in global healthcare and biotech stocks with high growth potential backed by continued increase in demand resulting from aging population, thereby offering benefits of the investments to the Korean investors. In addition, global healthcare and biotech sectors have low correlation with the Korean equity market, ensuring diversification. Currency risk is efficiently managed as the currency will be hedge within the fund.
Second, S.A.M., the sub-advisor, has one of the largest U.S. biotech mutual fund AUM with. S.A.M.’s management capability has also been well-recognized, winning Lipper’s “Biotech-Best Fund over 5 years” in France, Spain and the Netherlands in 2006.
Third, investment professionals of “Pru Global Healthcare Equity Fund” select stocks by leveraging Scientific Advisory Network (S.A.N.) composed of scientists who have been recognized in the global scientific arena for their respective expertise.
“Pru Global Healthcare Equity Fund” is a type of product only a few have introduced in Korea so far, and it is designed to share with the clients the benefits of investing in global healthcare and biotech sectors that have high growth potential supported by the aging population,” said Jinho Chung, CEO at PISC., “Going forward, we will continue to leverage Prudential’s global network to do our best in offering products that contribute to the growth and protection of clients’ assets,” added Chung.
웹사이트: http://www.prucyber.com
연락처
Jae-Hwan Lee 822-3770-7373
Kyun-Jang Lee 822-3770-7577
-
2008년 7월 21일 10:52